Porton Pharma Solutions Ltd. (SHE:300363)

Porton Pharma Solutions Revenue

Porton Pharma Solutions had revenue of 974.81M CNY in the quarter ending September 30, 2026, with 5.56% growth. This brings the company's total for the last twelve months to 3.64B, up 6.09% year-over-year. In the year 2025, Porton Pharma Solutions had annual revenue of 3.42B with 13.54% growth. That makes Porton Pharma Solutions the 10,759th largest company in the world by revenue and 1,785th in China.

• Revenue (ttm): 3.64B
• Revenue Growth: +6.09%
• P/S Ratio: 3.08
• Revenue / Employee: 827.30K
• Employees: 4,400
• Market Cap: 11.34B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Small Molecule Api Business 3.09B 90.4%
• Emerging Business 304.96M 8.9%
• Other Operations 22.98M 0.7%

By Geography

Chart

• Overseas 2.33B 68.2%
• China 1.09B 31.8%

Fiscal year ended Dec 31, 2025 See the full Porton Pharma Solutions breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.42B	407.86M	13.54%
Dec 31, 2024	3.01B	-655.45M	-17.87%
Dec 31, 2023	3.67B	-3.37B	-47.87%
Jan 1, 2023	7.03B	3.93B	126.55%
Jan 1, 2022	3.11B	1.03B	49.87%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error